Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Rectal Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Colonic Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Kidney Neoplasms 4Colorectal Neoplasms 4Carcinoma, Renal Cell 4Lymphoma, Large-Cell, Immunoblastic 3Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lung Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2HIV Infections 2Congenital Abnormalities 2Burkitt Lymphoma 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Smoldering Multiple Myeloma 1

Interventions

Docetaxel 3nimotuzumab 1WW Domain-Containing Oxidoreductase 1Vinorelbine 1Paclitaxel 1Gene Expression Profiling 1Gemcitabine 1Erlotinib Hydrochloride 1Carboplatin 1Capecitabine 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Advanced Non-Small Cell Lung Cancer × Gene Expression Profiling × Clear all
NCT00161278 2008-07-30

Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling

University of Michigan Rogel Cancer Center

Phase 2 Terminated
1 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡